Trial Profile
Gimeracil/oteracil/tegafur + paclitaxel vs gimeracil/oteracil/tegafur + cisplatin in patients with unresectable and/or recurrent gastric cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Jul 2012
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Paclitaxel (Primary) ; Cisplatin
- Indications Gastric cancer
- Focus Therapeutic Use
- 30 Jul 2012 New trial record